Treatment of depression or generalized anxiety disorder

Details Treatment of depression or generalized anxiety disorder Treatment of depression or generalized anxiety disorder

2005-05-03

2005-05-03

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

C514S249000

Reexamination Certificate

active

06887905

ABSTRACT:
A pharmaceutical composition for treating a disorder that is treated by modulation of serotonergic neurotransmission comprising administering (7S,9aS)-cis-2-Benzo[d]isoxazol-3-yl-7-(3-pyrrolidin-1-ylmethyl-phenoxymethyl)-octahydro-pyrido-[1,2-a]pyrazine and sertraline is disclosed.

REFERENCES:
Robichard et al., Annual Reports in Medicinal Chemistry, vol. 35, pp. 11-20 (2000).

Affiliated with

Also associated with

Rating

Treatment of depression or generalized anxiety disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of depression or generalized anxiety disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of depression or generalized anxiety disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3372691